Accueil>>Signaling Pathways>> Apoptosis>> PD-1/PD-L1 interaction>>Serplulimab

Serplulimab (Synonyms: HLX 10)

Catalog No.GC66378

Le serplulimab (HLX 10) est un anticorps monoclonal humanisé anti-PD-1. Le serplulimab peut être utilisé dans la recherche sur le cancer du poumon À petites cellules.

Products are for research use only. Not for human use. We do not sell to patients.

Serplulimab Chemical Structure

Cas No.: 2231029-82-4

Taille Prix Stock Qté
1mg
90,00 $US
En stock
5mg
315,00 $US
En stock
10mg
504,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Serplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody. Serplulimab can be used in research of small cell lung cancer[1].

Avis

Review for Serplulimab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Serplulimab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.